Inge Holm Lauritzen
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Inge Holm Lauritzen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.
9
| Extinct | Chemicals: Specialty | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Inge Holm Lauritzen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CHEVRON CORPORATION | Integrated Oil | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | President Director of Finance/CFO Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANDVIK AB | Trucks/Construction/Farm Machinery | Human Resources Officer | |
| AMYRIS, INC. | Chemicals: Specialty | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GN STORE NORD A/S | Telecommunications Equipment | Chairman Corporate Officer/Principal | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Director/Board Member | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Director/Board Member | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| MARSHALL BOYA VE VERNIK SANAYII | Industrial Specialties | Human Resources Officer | |
| Carleton College | College/University | Undergraduate Degree | |
| Seattle University | College/University | Graduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of New Hampshire | College/University | Doctorate Degree | |
| University of Aarhus | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| Technical University of Denmark | College/University | Corporate Officer/Principal Graduate Degree | |
US Department of Energy (District of Columbia)
 US Department of Energy (District of Columbia) General GovernmentGovernment US Department of Energy Develops energy technologies for buildings, homes, transportation power systems and industry. The company was founded in 1977 and is headquartered in Washington, DC. | General Government | Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Southern Denmark | College/University | Graduate Degree Doctorate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Chairman Founder | |
| Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | ||
ACADIA Pharmaceuticals A/S
 ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Miscellaneous Commercial Services | Founder | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Founder Director/Board Member | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | Chairman General Counsel | |
| Scandinavian Society for Psychopharmacology | Corporate Officer/Principal | ||
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Generic | Director/Board Member | |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder | |
| Edinburgh Business School | College/University | Masters Business Admin | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MONSENSO A/S | Internet Software/Services | Director/Board Member Director/Board Member | |
| CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Akzonobel Decorative Coatings Ltd. | Director/Board Member | ||
| Munir Sahin Ilaç Sanayi Ve Ticaret AS | Human Resources Officer | ||
| Tissue Link ApS | Founder | ||
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member Director/Board Member | |
| Lundbeck Cognitive Therapeutics A/S | Director/Board Member Chairman |
Statistik
International
| Dänemark | 27 |
| Vereinigte Staaten | 11 |
| Niederlande | 4 |
| Türkei | 3 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Process Industries | 3 |
| Energy Minerals | 2 |
Operativ
| Director/Board Member | 184 |
| Corporate Officer/Principal | 86 |
| Chairman | 84 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 32 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Inge Holm Lauritzen
- Unternehmensverbindungen